Nymox Pharmaceutical Corporation Cash and Cash Equivalents 2011-2025 | NYMX

Annual Cash and Cash Equivalents Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	830 K	3.61 M	5.24 M	7.95 M	851 K	2.02 M	374 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.95 M	374 K	2.98 M

Quarterly Cash and Cash Equivalents Nymox Pharmaceutical Corporation

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	672 K	830 K	3.14 M	6.2 M	880 K	3.61 M	5.36 M	767 K	3 M	5.24 M	7.14 M	9.1 M	11.3 M	7.95 M	4.66 M	5.04 M	850 K	851 K	1.74 M	1.26 M	1.63 M	2.02 M	-	-	-	374 K	-	-	-	632 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.3 M	374 K	3.51 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	152 M	$ 25.27	-2.43 %	$ 1.22 B	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	26.3 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	24.6 M	$ 3.26	-3.12 %	$ 252 M	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Kamada Ltd. KMDA	78.4 M	$ 7.03	0.14 %	$ 260 M	Israel
Ascendis Pharma A/S ASND	560 M	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	5.67 M	$ 0.91	-5.01 %	$ 18.7 M	Israel
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.3	-3.51 %	$ 7.94 B	Australia
AstraZeneca PLC AZN	5.49 B	$ 89.78	-0.57 %	$ 96.9 B	Britain
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Anika Therapeutics ANIK	72.9 M	$ 9.57	0.84 %	$ 140 M	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	2.63 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	97.7 M	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	31 M	$ 2.34	2.59 %	$ 14.7 M	USA
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Aptorum Group Limited APM	3.5 M	$ 1.29	-3.01 %	$ 7.03 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Baudax Bio BXRX	5.26 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Catalyst Biosciences CBIO	33.5 M	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	44.5 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	455 M	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	20.3 M	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	6.6 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	16.2 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	143 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	2.38 B	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	17.5 M	$ 1.42	-5.96 %	$ 2.1 M	USA
Celldex Therapeutics CLDX	28.4 M	$ 27.36	-2.09 %	$ 1.76 M	USA
Cortexyme CRTX	20.8 M	-	-1.05 %	$ 67.1 M	USA
Cellectar Biosciences CLRB	9.56 M	$ 3.63	-3.97 %	$ 44.4 M	USA
Deciphera Pharmaceuticals DCPH	83.5 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	172 M	$ 11.54	0.87 %	$ 746 M	USA